GH Strategies is a regulatory, quality, and strategic consulting partner for pharmaceutical, medical device, biotechnology, and healthcare organisations across Africa.
We design inspection-ready systems that allow regulated businesses to operate with certainty.
Our work spans the full product lifecycle – from SAHPRA establishment licensing and medicine registration to ISO 13485 implementation, pharmacovigilance system design, clinical trial supply chain oversight, and market access strategy.
We integrate regulatory affairs, quality systems, and operational governance to ensure compliance becomes a competitive advantage – not a constraint.
For organisations where regulatory precision, audit readiness, and long-term credibility matter, GH Strategies delivers structured execution and strategic clarity.
